Covington Capital Management’s Clover Health Investments CLOV Stock Holding History

Covington Capital Management’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$0	Buy	+200	New	+$524	﹤0.01%	1198

Other funds holding CLOV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Covington Capital Management's CLOV Position: Q3 2022 in Review

Covington Capital Management opened a new position in Clover Health Investments (CLOV) in Q3 2022: 200 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1198 among its holdings.

175 funds tracked by Wall St. Rank hold CLOV as of Q3 2022.

Covington Capital Management held 200 shares of Clover Health Investments worth $0 as of Q3 2022.
Clover Health Investments was a new Covington Capital Management position in Q3 2022.
Clover Health Investments made up ﹤0.01% of Covington Capital Management's portfolio in Q3 2022, its #1198 holding.
175 funds tracked by Wall St. Rank held Clover Health Investments as of Q3 2022.

Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.